MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about issue of duplicate share certificates

27 Feb 2024 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.90
Dr. Reddys Labs. 1147.55
Cipla 1359.30
Lupin 2045.05
Zydus Lifesciences 1107.90
View more..